AU2009240511B2 - Thiolated chitosan gel - Google Patents

Thiolated chitosan gel Download PDF

Info

Publication number
AU2009240511B2
AU2009240511B2 AU2009240511A AU2009240511A AU2009240511B2 AU 2009240511 B2 AU2009240511 B2 AU 2009240511B2 AU 2009240511 A AU2009240511 A AU 2009240511A AU 2009240511 A AU2009240511 A AU 2009240511A AU 2009240511 B2 AU2009240511 B2 AU 2009240511B2
Authority
AU
Australia
Prior art keywords
thiolated chitosan
fluid layer
chitosan
layer
thiolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009240511A
Other languages
English (en)
Other versions
AU2009240511A1 (en
Inventor
Maria Nieves Gonzalez
Nancy Schaffhausen
Edze Jan Tijsma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40745190&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2009240511(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of AU2009240511A1 publication Critical patent/AU2009240511A1/en
Application granted granted Critical
Publication of AU2009240511B2 publication Critical patent/AU2009240511B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2009240511A 2008-04-24 2009-04-23 Thiolated chitosan gel Ceased AU2009240511B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4759008P 2008-04-24 2008-04-24
US61/047,590 2008-04-24
US5503708P 2008-05-21 2008-05-21
US61/055,037 2008-05-21
PCT/US2009/041590 WO2009132226A1 (en) 2008-04-24 2009-04-23 Thiolated chitosan gel

Publications (2)

Publication Number Publication Date
AU2009240511A1 AU2009240511A1 (en) 2009-10-29
AU2009240511B2 true AU2009240511B2 (en) 2015-01-22

Family

ID=40745190

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009240511A Ceased AU2009240511B2 (en) 2008-04-24 2009-04-23 Thiolated chitosan gel

Country Status (7)

Country Link
US (1) US20090269417A1 (cg-RX-API-DMAC10.html)
EP (1) EP2313104B2 (cg-RX-API-DMAC10.html)
JP (1) JP5711113B2 (cg-RX-API-DMAC10.html)
CN (1) CN102159220A (cg-RX-API-DMAC10.html)
AU (1) AU2009240511B2 (cg-RX-API-DMAC10.html)
CA (1) CA2721985C (cg-RX-API-DMAC10.html)
WO (1) WO2009132226A1 (cg-RX-API-DMAC10.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102399295B (zh) * 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
US9486190B2 (en) 2011-10-28 2016-11-08 Medtronic Xomed, Inc. Spray delivery system
US10441959B2 (en) * 2011-10-28 2019-10-15 Medtronic Xomed, Inc. Multi-orifice spray head
US9987391B2 (en) 2013-03-13 2018-06-05 St. Jude Medical Coordination Center Bvba Injectable hydrogels
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
US9480828B2 (en) 2013-11-14 2016-11-01 Gyrus Acmi, Inc. Treatment method for the inferior turbinate
EP3139903B1 (en) 2014-05-07 2019-07-03 Croma-Pharma Gesellschaft m.b.H. Aqueous ophthalmic solution and method for treating dry eye syndrome
PL3368006T3 (pl) 2015-10-30 2020-06-01 Croma-Pharma Gesellschaft M.B.H. Zastosowanie terapeutyczne sterylnego wodnego roztworu oftalmicznego
CN108348455B (zh) 2015-10-30 2021-04-09 克罗马药品股份有限公司 无菌水性眼用溶液的治疗用途
CN107684550B (zh) * 2016-08-03 2020-04-10 徐天宏 糖尿病治疗产品及其制备与应用
CN107684551A (zh) * 2016-08-03 2018-02-13 徐天宏 糖尿病或肥胖疾病治疗产品及其制备与应用
WO2018202783A1 (en) 2017-05-03 2018-11-08 Croma-Pharma Gmbh Sterile aqueous ophthalmic solution containing n-(n-acetylcysteinyl)-chitosan for treating non-infectious corneal disorders
JP7339267B2 (ja) * 2017-11-07 2023-09-05 ロイヤル カレッジ オブ サージョンズ イン アイルランド 固形腫瘍癌の治療としての腫瘍内投与のための熱応答性ヒドロゲル
CN112334167A (zh) 2018-06-15 2021-02-05 克罗马药品有限责任公司 包含交联聚合物的水凝胶组合物
BR112020024654B1 (pt) 2018-06-15 2024-02-27 Croma-Pharma Gmbh Composição de hidrogel estéril, unidade de aplicação para injeção,seus usos, método cosmético, enchimento de tecido mole, e implante ou depósito
WO2021123247A1 (en) 2019-12-19 2021-06-24 Croma-Pharma Gmbh Thiol-modified hyaluronan and hydrogel comprising the crosslinked hyaluronan

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007071375A1 (en) * 2005-12-22 2007-06-28 Unilever Plc Antiperspirant compositions
WO2008008857A2 (en) * 2006-07-11 2008-01-17 University Of Utah Research Foundation Thiolated macromolecules and methods of making and using thereof

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184385A (en) * 1961-10-16 1965-05-18 Eastman Kodak Co Dry, vitamin-active product and process for preparing same
US3989044A (en) * 1975-08-11 1976-11-02 Warner-Lambert Company Syringe
EP0112852B1 (en) * 1982-06-24 1988-06-08 SMITH, Robert Alan Pharmaceutical gel composition
JPS62123112A (ja) * 1985-11-22 1987-06-04 Sunstar Inc 軟膏基剤
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5308546A (en) * 1991-12-09 1994-05-03 Glow-Tec Phosphorescent toy gel composition and methods of manufacture
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
GB2276819B (en) * 1993-03-23 1996-12-11 Johnson & Johnson Medical Aqueous wound treatment composition comprising a polysaccharide and hexylene glycol
US5622834A (en) * 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
WO1997022371A1 (en) * 1995-12-18 1997-06-26 Collagen Corporation Crosslinked polymer compositions and methods for their use
IL118376A0 (en) * 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US20050096282A1 (en) * 1997-04-21 2005-05-05 Lewin Alfred S. Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
DE10035799A1 (de) * 2000-07-22 2002-01-31 Kalle Nalo Gmbh & Co Kg Nach dem Aminoxidverfahren hergestellte Nahrungsmittelhüllen auf Cellulosebasis
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
EP1392182A1 (en) * 2001-05-04 2004-03-03 Concentric Medical Hydrogel vaso-occlusive device
US20060004314A1 (en) * 2001-06-14 2006-01-05 Hemcon, Inc. Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan
ATA13842001A (de) * 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
DE10152407A1 (de) * 2001-10-24 2003-05-08 Aesculap Ag & Co Kg Zusammensetzung aus mindestens zwei biokompatiblen chemisch vernetzbaren Komponenten
US6664301B1 (en) * 2002-02-20 2003-12-16 Robert D. Kross Method for using glycol additives to texturally modify natural gum hydrogels
US20050019404A1 (en) * 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
DE10318802A1 (de) * 2003-04-17 2004-11-04 Aesculap Ag & Co. Kg Selbsthaftendes resorbierbares Hämostyptikum
US8124120B2 (en) * 2003-12-22 2012-02-28 Anika Therapeutics, Inc. Crosslinked hyaluronic acid compositions for tissue augmentation
US7282194B2 (en) * 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US8703659B2 (en) * 2005-01-24 2014-04-22 Halliburton Energy Services, Inc. Sealant composition comprising a gel system and a reduced amount of cement for a permeable zone downhole
US7834065B2 (en) * 2005-01-31 2010-11-16 Bmg Incorporated Medical-use two part reactive adhesive and medical-use resin having self-degradation property
WO2006092799A1 (en) * 2005-03-02 2006-09-08 Polyrizon Ltd. Method for removal of toxins from mucosal membranes
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
DE102005030011A1 (de) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Verfahren zur Herstellung von sterilen Polysaccharidlösungen
US20070031467A1 (en) * 2005-08-04 2007-02-08 Abrahams John M Composition and method for vascular embolization
FR2889449B1 (fr) * 2005-08-05 2011-06-10 Khorionyx Preparations implantables
US20080069857A1 (en) * 2006-04-12 2008-03-20 Yoon Yeo Compositions And Methods For Inhibiting Adhesions
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
US20070243130A1 (en) * 2006-04-18 2007-10-18 Weiliam Chen Biopolymer system for tissue sealing
US7854923B2 (en) * 2006-04-18 2010-12-21 Endomedix, Inc. Biopolymer system for tissue sealing
US20090010982A1 (en) * 2006-04-18 2009-01-08 Endomedix, Inc. Biocompatible adherent sheet for tissue sealing
BRPI0721211A2 (pt) * 2007-02-08 2013-01-15 Medtronic Xomed Inc uso de um tensoativo e um selante mÉdico, mÉtodo para tratar as condiÇÕes de ouvido, nariz e garganta, e, composiÇço
JP2009040697A (ja) * 2007-08-07 2009-02-26 Asuka Corporation:Kk 化粧料組成物
US20090062233A1 (en) * 2007-08-09 2009-03-05 Xin Ji Modified starch material of biocompatible hemostasis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007071375A1 (en) * 2005-12-22 2007-06-28 Unilever Plc Antiperspirant compositions
WO2008008857A2 (en) * 2006-07-11 2008-01-17 University Of Utah Research Foundation Thiolated macromolecules and methods of making and using thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BERNKOP-SCHNURCH et al., "Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system", International Journal of Pharmaceutics, 2006, Vol. 317, No. 1, pages 76-81 *

Also Published As

Publication number Publication date
EP2313104A1 (en) 2011-04-27
CN102159220A (zh) 2011-08-17
EP2313104B2 (en) 2020-08-26
CA2721985A1 (en) 2009-10-29
EP2313104B1 (en) 2017-11-01
US20090269417A1 (en) 2009-10-29
JP2011518619A (ja) 2011-06-30
JP5711113B2 (ja) 2015-04-30
AU2009240511A1 (en) 2009-10-29
WO2009132226A1 (en) 2009-10-29
CA2721985C (en) 2016-06-21

Similar Documents

Publication Publication Date Title
EP2313104B1 (en) Thiolated chitosan gel
CA2721937C (en) Protective gel based on chitosan and oxidized polysaccharide
US8530632B2 (en) Chitosan-containing protective composition
EP2291448B1 (en) Rehydratable polysaccharide particles and sponge
EP3060265B1 (en) Chitosan stenting paste
AU2009240509B2 (en) Rehydratable thiolated polysaccharide particles and sponge
US9192692B2 (en) Chitosan stenting paste

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired